| Literature DB >> 31444181 |
Yijia Chen1,2, Jie Yang2, Jian Su2, Yu Qin2, Chong Shen3, Ying Li1, Shurong Lu2, Enchun Pan4, Yan Gao5, Dandan Miao4, Ning Zhang6, Jinyi Zhou1,2, Ming Wu7,2.
Abstract
OBJECTIVE: Investigating the association between total physical activity, physical activity in different domains and sedentary time with clustered metabolic risk in patients with type 2 diabetes from Jiangsu province, China.Entities:
Keywords: cross-sectional study; metabolic risk; physical activity; sedentary time; type 2 diabetes
Mesh:
Year: 2019 PMID: 31444181 PMCID: PMC6707692 DOI: 10.1136/bmjopen-2018-027906
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Demographic, metabolic characteristics of participants
| characteristic | Men | Women | Total | P value |
| N | 7041 | 10 709 | 17 750 | |
| Age (years) | 62.6±9.9 | 62.8±9.7 | 62.8±9.8 | 0.11 |
| High school or above (%) | 17.7 | 4.5 | 9.8 | <0.001 |
| Annual income >¥40 000 (%) | 64.8 | 57.0 | 60.1 | <0.001 |
| Body mass index (kg/m2) | 25.3±3.2 | 25.4±3.6 | 25.3±3.4 | 0.09 |
| Waist circumference (cm) | 87.9±9.4 | 85.5±9.5 | 86.4±9.5 | <0.001 |
| Systolic blood pressure (mm Hg) | 147.3±19.8 | 148.9±21.1 | 148.0±20.6 | 0.002 |
| Diastolic blood pressure (mm Hg) | 83.7±10.7 | 79.9±10.4 | 81.4±10.6 | <0.001 |
| Triacylglycerol (mmol/L)* | 1.4 (1.0, 2.2) | 1.7 (1.2, 2.3) | 1.6 (1.1, 2.3) | <0.001 |
| HDL-cholesterol (mmol/L) | 1.4±0.4 | 1.5±0.4 | 1.5±0.4 | <0.001 |
| Fasting plasma glucose (mmol/L)* | 8.2 (6.4, 10.2) | 8.0 (6.5, 9.9) | 8.1 (6.6, 10.0) | <0.001 |
| HbA1c (mmol/mol)* | 56.3 (46.5, 70.5) | 55.2 (46.5, 68.3) | 55.2 (46.5, 69.4) | <0.001 |
| Diabetes duration (years)* | 5 (2, 9) | 5 (2, 9) | 5 (2, 9) | 0.26 |
| Smoking (%) | 46.0 | 6.2 | 22.0 | <0.001 |
| Alcohol consumption (%) | ||||
| Never | 49.1 | 96.6 | 77.7 | <0.001 |
| Former | 10.7 | 1.1 | 4.9 | <0.001 |
| Current | 40.1 | 2.3 | 17.4 | <0.001 |
| On glucose-lowering medication (%) | 78.7 | 78.4 | 78.5 | 0.60 |
| On lipid-lowering medication (%) | 5.8 | 5.9 | 6.0 | 0.005 |
| On antihypertensive medication (%) | 52.7 | 53.9 | 53.4 | 0.002 |
| Hypertension (%) | 77.5 | 76.6 | 77.0 | 0.16 |
| Dyslipidaemia (%) | 46.1 | 49.3 | 48.0 | <0.001 |
| Total physical activity (MET hours/day)* | 6.3 (2.3, 14.3) | 8.0 (3.4, 16.0) | 8.0 (2.9, 15.4) | <0.001 |
| Physical activity domains (MET hours/day)† | ||||
| Occupational | 68.2 (2.9 (0.0, 8.6)) | 81.9 (5.1 (1.7, 12.0)) | 76.5 (4.0 (0.6, 12.0)) | <0.001‡ |
| Commuting | 59.4 (1.1 (0.0, 1.3)) | 62.0 (1.0 (0.0, 2.9)) | 60.1 (1.0 (0.0, 2.9)) | <0.001‡ |
| Leisure times | 25.6 (3.1 (1.7, 6.0)) | 19.0 (2.9 (1.5, 5.1)) | 21.6 (3.0 (1.7, 5.7)) | <0.001‡ |
| Sedentary time (hours/day) | 3.5±2.5 | 3.4±2.6 | 3.4±2.5 | <0.001 |
| Sleep duration (hours/day) | 7.4±1.6 | 7.3±1.7 | 7.4±1.7 | <0.001 |
P values are from Student’s t-test or Mann-Whitney U test for continuous variables and from χ2 test for categorical variables.
Data are mean±SD unless stated otherwise.
*Median (IQR).
†(%) Median (IQR).
‡ P values are from χ2 test.
HDL, high-density lipoprotein; HbA1c, glycated haemoglobin; MET, metabolic equivalent.
Adjusted means (SE) of metabolic variables by quartile of physical activity and sedentary time
| Metabolic risk | Total physical activity (MET hours/day) | Sedentary time (hours/day) | ||||||||
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P for trend | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P for trend | |
| zMS* | 0.28 (0.04)‡ § ¶ | 0.01 (0.04)† ¶ | −0.11 (0.05)† | −0.21 (0.04)† ‡ | <0.001 | −0.16 (0.03)§ ¶ | −0.07 (0.10)¶ | 0.004 (0.03)† ¶ | 0.29 (0.04)† ‡ § | <0.001 |
| Waist circumference (cm) | 87.19 (0.14)‡ § ¶ | 86.56 (0.13)† ¶ | 86.13 (0.16)† | 85.76 (0.14)† ‡ | <0.001 | 85.98 (0.11)¶ | 86.25 (0.16) | 86.57 (0.20)¶ | 87.30 (0.14)† § | <0.001 |
| Fasting plasma glucose (mmol/L)** | 2.13 (0.005)§ | 2.12 (0.005)§ | 2.10 (0.005)† § | 2.12 (0.005) | 0.427 | 2.11 (0.004)¶ | 2.10 (0.012)¶ | 2.12 (0.005)¶ | 2.14 (0.005)† ‡ § | <0.001 |
| Triacylglycerol (mmol/L)** | 0.54 (0.008)‡ § ¶ | 0.50 (0.008)† ¶ | 0.48 (0.009)† | 0.45 (0.008)† ‡ | <0.001 | 0.46 (0.006)§ ¶ | 0.47 (0.021)¶ | 0.50 (0.008)† ¶ | 0.54 (0.009)† ‡ § | <0.001 |
| HDL-cholesterol (mmol/L) | 1.45 (0.01)‡ § ¶ | 1.49 (0.01)† ¶ | 1.50 (0.01)† | 1.52 (0.01)† ‡ | <0.001 | 1.51 (0.01)§ ¶ | 1.48 (0.01)¶ | 1.48 (0.01)† ¶ | 1.46 (0.01)† ‡ § | <0.001 |
| Systolic blood pressure (mm Hg) | 148.26 (0.30) | 147.91 (0.28) | 147.80 (0.34) | 148.05 (0.30) | 0.651 | 148.08 (0.23) | 147.56 (0.33) | 147.87 (0.42) | 148.35 (0.30) | 0.326 |
Date are mean (SE) values for each quartile of physical activity and sedentary time, adjusted for age and sex by using general linear regression models. Test for trend based on variable containing median value for each quartiles. Multiple comparison between the groups was performed using Bonferroni method.
*zMS is a continuously distribute variable for clustered metabolic risk calculated by summing sex-specific standardised values for waist circumference, fasting plasma glucose, triacylglycerol, systolic blood pressure and the inverse of HDL-cholesterol.
†Significantly different compared with quartile 1 (p< 0.05).
‡Significantly different compared with quartile 2 (p< 0.05).
§Significantly different compared with quartile 3 (p< 0.05).
¶Significantly different compared with quartile 4 (p< 0.05).
**Fasting plasma glucose and triacylglycerol were logarithmically transformed (base e) due to their skewed distribution.
HDL, high-density lipoprotein; MET, metabolic equivalent; zMS, Score of Clustered Metabolic Risk.
Cross-sectional linear regression analysis of association of physical activity and sedentary time with metabolic variables
| Metabolic risk | Physical activity (per SD)* | Sedentary time | |||
| Total | Occupational | Commuting | Leisure time | ||
| zMS† | |||||
| Model 1 | −0.147 (−0.187, −0.108)*** | −0.132 (−0.171, –0.093)*** | −0.047 (−0.086, –0.007)§ | −0.068 (−0.107, –0.029)** | 0.188 (0.148, 0.227)*** |
| Model 2 | −0.091 (−0.126, −0.057)*** | −0.077 (−0.111, –0.042)*** | −0.013 (−0.047, 0.021) | −0.044 (−0.078, –0.010)§ | 0.128 (0.094, 0.162)*** |
| Model 3 | −0.080 (–0.115, –0.046)*** | −0.066 (–0.101, –0.031)*** | −0.011 (–0.045, 0.022) | −0.042 (–0.076,–0.008)§ | 0.121 (0.087, 0.155)*** |
| Model 4 | −0.080 (–0.114, –0.046)*** | −0.066 (–0.101, –0.031)*** | −0.011 (–0.045, 0.023) | −0.041 (–0.075,–0.007)§ | 0.117 (0.083, 0.151)*** |
| Waist circumference (cm) | |||||
| Model 1 | −0.552 (–0.692, –0.412)*** | −0.625 (–0.765,–0.485)*** | 0.096 (–0.044, 0.237) | −0.026 (–0.167, 0.114) | 0.575 (0.435, 0.715)*** |
| Model 2 | −0.495 (–0.635, –0.355)*** | −0.519 (–0.661,–0.376)*** | 0.021 (–0.118, 0.161) | −0.051 (–0.191, 0.089) | 0.525 (0.386, 0.663)*** |
| Model 3 | −0.450 (−0.591, -0.309)*** | −0.475 (−0.618,–0.332)*** | 0.028 (−0.112, 0.167) | −0.042 (−0.182, 0.098) | 0.483 (0.344, 0.623)*** |
| Model 4 | −0.449 (−0.591, −0.308)*** | −0.475 (−0.620,–0.334)*** | 0.030 (−0.109, 0.170) | −0.039 (−0.179, 0.102) | 0.474 (0.334, 0.613)*** |
| Fasting plasma glucose (mmol/L)§ | |||||
| Model 1 | 0.005 (0.000, 0.010) | 0.007 (0.002, 0.012)** | −0.005 (−0.010, 0.000) | −0.001 (−0.006, 0.004) | 0.011 (0.006, 0.016)*** |
| Model 2 | 0.003 (−0.002, 0.007) | 0.005 (−0.001, 0.009) | −0.001 (−0.005, 0.004) | −0.002 (−0.007, 0.002) | 0.008 (0.004, 0.013)*** |
| Model 3 | 0.004 (−0.001, 0.008) | 0.005 (−0.001, 0.010) | −0.001 (−0.005, 0.004) | −0.002 (−0.007, 0.003) | 0.009 (0.004, 0.013)*** |
| Model 4 | 0.004 (−0.001, 0.008) | 0.005 (−0.001, 0.009) | −0.001 (−0.005, 0.004) | −0.002 (−0.006, 0.003) | 0.008 (0.003, 0.013)*** |
| Triacylglycerol (mmol/L)§ | |||||
| Model 1 | −0.022 (−0.030, −0.013)*** | −0.017 (–0.025, –0.009)** | −0.015 (−0.024, –0.007)*** | −0.020 (−0.019, –0.003)** | 0.031 (0.023, 0.039)*** |
| Model 2 | −0.014 (−0.021, −0.007)*** | −0.009 (−0.015, –0.002)§ | −0.012 (−0.019, –0.005)*** | −0.007 (−0.014, –0.001)§ | 0.017 (0.010, 0.024)*** |
| Model 3 | −0.012 (−0.019, −0.006)*** | −0.007 (−0.014, –0.001)§ | −0.012 (−0.019, –0.005)*** | −0.006 (−0.013, 0.001) | 0.016 (0.009, 0.023)*** |
| Model 4 | −0.012 (−0.019, -0.006)*** | −0.007 (−0.014, –0.001)§ | −0.012 (−0.019, –0.005)*** | −0.006(−0.013, 0.001) | 0.015 (0.008, 0.022)*** |
| HDL-cholesterol (mmol/L) | |||||
| Model 1 | 0.015 (0.009, 0.022)*** | 0.016 (0.009, 0.022)** | 0.002 (−0.005, 0.008) | 0.003 (−0.004, 0.009) | −0.019 (−0.025, −0.012)*** |
| Model 2 | 0.010 (0.004, 0.016)*** | 0.007 (0.001, 0.013)§ | 0.003 (−0.003, 0.009) | 0.007 (−0.001, 0.013) | −0.008 (−0.014, -0.002)§ |
| Model 3 | 0.009 (0.003, 0.015)*** | 0.006 (0.001, 0.013)§ | 0.003 (−0.003, 0.009) | 0.007 (−0.001, 0.013) | −0.007 (−0.013, -0.001)§ |
| Model 4 | 0.009 (0.003, 0.015)*** | 0.006 (0.001, 0.013)§ | 0.003 (−0.003, 0.009) | 0.007 (−0.001, 0.013) | −0.007 (-0.013, −0.001)§ |
| Systolic blood pressure (mm Hg) | |||||
| Model 1 | −0.907 (−1.209, −0.604)*** | −0.625 (−0.928, -0.322)*** | −0.549 (−0.852, –0.246)*** | −0.871 (−1.174, –0.568)*** | 0.340 (0.037, 0.643)§ |
| Model 2 | −0.110 (−0.359, 0.139) | 0.065 (−0.187, 0.317) | −0.212 (−0.459, 0.034) | −0.300 (−0.548, –0.052)§ | 0.224 (−0.022, 0.470) |
| Model 3 | −0.091 (−0.341, 0.159) | 0.084 (−0.169, 0.337) | −0.210 (−0.456, 0.037) | −0.296 (−0.544, –0.048)§ | 0.216 (−0.031, 0.462) |
| Model 4 | −0.096 (−0.346, 0.155) | 0.081 (−0.173, 0.334) | −0.219 (−0.466, 0.028) | −0.293 (−0.542, –0.045)§ | 0.215 (−0.033, 0.462) |
Regression results are presented as unstandardised coefficients (B) (95% CI).
All models (except model 1) are adjusted for age, sex, education, annual household income, smoking status, alcohol consumption and diabetes duration. All outcomes except zMS and waist circumference are additionally adjusted for waist circumference. Fasting plasma glucose is additional adjusted for the use of glucose-lowering medication (yes/no); triacylglycerol and HDL-cholesterol are additionally adjusted for the diagnosis of dyslipidaemia (yes/no) and the use of lipid-lowing drugs (yes/no/unclear); systolic blood pressure is additionally adjusted for the diagnosis of hypertension(yes/no) and the use of antihypertension medication (yes/no/unclear); and zMS is additional adjusted for the use of glucose-lowering medication (yes/no), lipid-lowing medication (yes/no/unclear) and antihypertension medication (yes/no/unclear), the diagnosis of dyslipidaemia (yes/no) and the diagnosis of hypertension(yes/no).
Model 3 is adjusted for remaining physical activity and sedentary time as appropriate; model 4 is additional adjusted for sleep duration.
*Per-SD of physical activity=13.8 MET hours/day, per SD of occupational physical activity=12.6 MET hours/day, per SD of commuting physical activity=3.2 MET hours/day, per SD of leisure-time physical activity=3.4 MET hours/day, per SD sedentary time=2.5 hours/day.
†zMS is a continuously distribute variable for clustered metabolic risk calculated by summing sex-specific standardised values for waist circumference, fasting plasma glucose, triacylglycerol, systolic blood pressure and the inverse of HDL-cholesterol.
‡Fasting plasma glucose and triacylglycerol were logarithmically transformed (base e) due to their skewed distribution.
§P<0.05; **P<0.01; ***P<0.001.
HDL, high-density lipoprotein; MET, metabolic equivalent; zMS, Score of Clustered Metabolic Risk.
Figure 1Means of clustered metabolic risk scores by sedentary time and physical activity among 17 750 patients with diabetes. The adjusted mean was calculated using general linear regression models after adjustment for age. For physical activity, in men, the cut-off values for defining low, moderate and high tertile groups were 4.00 and 11.14 MET hours/day, while they were 4.57 and 12.00 MET hours/day for women. For sedentary time, the four groups by quartiles of sedentary time were <2.2, 2.3–3.3, 3.4–4.9 and ≥5.0 hours/day for men and <2.2, 2.3–3.3, 3.4–4.4 and ≥4.5 hours/day for women.